Ceramide analog SACLAC modulates sphingolipid levels and Mcl-1 splicing to induce apoptosis in acute myeloid leukemia

Acute myeloid leukemia (AML) is a disease characterized by uncontrolled proliferation of immature myeloid cells in the blood and bone marrow. The five-year survival rate is approximately 25%, and recent therapeutic developments have yielded little survival benefit. Therefore, there is an urgent need...

पूर्ण विवरण

में बचाया:
ग्रंथसूची विवरण
में प्रकाशित:Mol Cancer Res
मुख्य लेखकों: Pearson, Jennifer M., Tan, Su-Fern, Sharma, Arati, Annageldiyev, Charyguly, Fox, Todd E., Abad, Jose Luis, Fabrias, Gemma, Desai, Dhimant, Amin, Shantu, Wang, Hong-Gang, Cabot, Myles C., Claxton, David F., Kester, Mark, Feith, David J., Loughran, Thomas P.
स्वरूप: Artigo
भाषा:Inglês
प्रकाशित: 2019
विषय:
Article
ऑनलाइन पहुंच:https://ncbi.nlm.nih.gov/pmc/articles/PMC7056541/
https://ncbi.nlm.nih.gov/pubmed/31744877
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1541-7786.MCR-19-0619
टैग : टैग जोड़ें
कोई टैग नहीं, इस रिकॉर्ड को टैग करने वाले पहले व्यक्ति बनें!

समान संसाधन